GLA
Great Lakes Advisors’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-615
| Closed | -$203K | – | 904 |
|
|
2024
Q2 | $203K | Sell |
615
-14
| -2% | -$4.61K | ﹤0.01% | 810 |
|
|
2024
Q1 | $249K | Buy |
629
+7
| +1% | +$2.77K | ﹤0.01% | 733 |
|
|
2023
Q4 | $219K | Sell |
622
-25
| -4% | -$8.8K | ﹤0.01% | 732 |
|
|
2023
Q3 | $243K | Sell |
647
-9
| -1% | -$3.38K | ﹤0.01% | 693 |
|
|
2023
Q2 | $251K | Sell |
656
-3
| -0.5% | -$1.15K | ﹤0.01% | 681 |
|
|
2023
Q1 | $228K | Buy |
+659
| New | +$228K | ﹤0.01% | 751 |
|
|
2022
Q3 | – | Sell |
-856
| Closed | -$259K | – | 721 |
|
|
2022
Q2 | $259K | Sell |
856
-1,022
| -54% | -$309K | 0.01% | 599 |
|
|
2022
Q1 | $771K | Buy |
1,878
+970
| +107% | +$398K | 0.01% | 474 |
|
|
2021
Q4 | $426K | Buy |
908
+6
| +0.7% | +$2.82K | 0.01% | 539 |
|
|
2021
Q3 | $383K | Buy |
902
+26
| +3% | +$11K | 0.01% | 558 |
|
|
2021
Q2 | $315K | Sell |
876
-1
| -0.1% | -$360 | ﹤0.01% | 575 |
|
|
2021
Q1 | $247K | Buy |
877
+1
| +0.1% | +$282 | ﹤0.01% | 621 |
|
|
2020
Q4 | $248K | Sell |
876
-10
| -1% | -$2.83K | ﹤0.01% | 572 |
|
|
2020
Q3 | $244K | Sell |
886
-52,490
| -98% | -$14.5M | 0.01% | 515 |
|
|
2020
Q2 | $12.1M | Buy |
53,376
+3,452
| +7% | +$784K | 0.29% | 103 |
|
|
2020
Q1 | $7.6M | Sell |
49,924
-209
| -0.4% | -$31.8K | 0.22% | 118 |
|
|
2019
Q4 | $7.54M | Sell |
50,133
-33,913
| -40% | -$5.1M | 0.16% | 162 |
|
|
2019
Q3 | $11.9M | Buy |
84,046
+2,960
| +4% | +$420K | 0.26% | 98 |
|
|
2019
Q2 | $10.1M | Buy |
81,086
+2,031
| +3% | +$254K | 0.22% | 111 |
|
|
2019
Q1 | $8.71M | Sell |
79,055
-10,939
| -12% | -$1.21M | 0.19% | 126 |
|
|
2018
Q4 | $8.82M | Buy |
89,994
+14,024
| +18% | +$1.37M | 0.21% | 119 |
|
|
2018
Q3 | $9.38M | Buy |
75,970
+17,758
| +31% | +$2.19M | 0.21% | 110 |
|
|
2018
Q2 | $5.78M | Sell |
58,212
-85
| -0.1% | -$8.44K | 0.14% | 174 |
|
|
2018
Q1 | $5.15M | Buy |
58,297
+34,597
| +146% | +$3.05M | 0.12% | 174 |
|
|
2017
Q4 | $2.34M | Buy |
+23,700
| New | +$2.34M | 0.05% | 294 |
|